PepGen is a biotechnology company that creates treatments for serious genetic muscle and nerve disorders. They are currently testing two main drug candidates in mid-stage clinical trials to address diseases like myotonic dystrophy. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
